Showing 2551-2560 of 3014 results for "".
- AnaptysBio, Inc.'s IL-33-Blocker Cleared for Phase 2a Trials in AD, Peanut Allergyhttps://practicaldermatology.com/news/anaptysbio-incs-il-33-blocker-cleared-for-phase-2a-trials-in-ad-peanut-allergy/2458347/The United Kingdom Medicines and Healthcare Products Regulatory Agency has green lighted a Phase 2a clinical trial for AnaptysBio, Inc.’s ANB020 for the treatment of adults with moderate-to-severe atopic dermatitis. The United States Food and Drug Ad
- Study: Anxiety Linked to Skin Diseasehttps://practicaldermatology.com/news/study-anxiety-linked-to-skin-disease/2458359/Anxiety disorders tend to be followed by skin diseases, according to psychologists at the University of Basel in Switzerland and Ruhr University Bochum in Germany. The study, which appears in the journa
- Beauty Drinks Poised to Be Cosmeceutical Industry's Next Billion-Dollar Babyhttps://practicaldermatology.com/news/beauty-drinks-poised-to-be-cosmeceutical-industrys-next-billion-dollar-baby/2458361/Beauty drinks are everywhere today, and many youth seekers turning to them as a way to improve skin and get their glow on from the inside out. In fact, beauty drinks are slated to become a billion dollar market, according to a new
- Merz On The Move: Reflections On Fiscal Year 2015/16https://practicaldermatology.com/news/merz-on-the-move-reflections-on-fiscal-year-201516/2458365/Merz Pharma’s core business has grown by 8.9 percent from EUR 809.8 million to EUR 881.9 million in fiscal 2015/16, the company reports. The company’s total revenue of EUR 1,092.9 million has declined by 5.5 percent compared to previous year
- New from Topix: Replenix® Pure Hydration Moisture Balmhttps://practicaldermatology.com/news/new-from-topix-replenix-pure-hydration-moisture-balm/2458368/The latest from Topix Pharmaceuticals, Inc., Replenix® Pure Hydration Moisture Balm, targets dry and aging skin. Various molecular weights of Hyaluronic Acid draw moisture into the skin and work with Yucca Glauca
- Food Allergy Linked to Early Exposure Through Broken Skinhttps://practicaldermatology.com/news/food-allergy-linked-to-early-exposure-through-broken-skin/2458369/Early exposure to a food allergen through broken skin might prompt the development of food allergy, according to new research in Allergy and Asthma Proceedings. This theory gained further support from a recent study that fo
- Derms Commonly Misdiagnose Fungal Skin Infectionshttps://practicaldermatology.com/news/fungal-skin-infections-commonly-misdiagnosed/2458372/Fungal skin infections may be commonly misdiagnosed, according to a survey in the Journal of the American Academy of Dermatology. George Washington University (GW) dermatologist Adam Friedman, MD and colleag
- Adriane M. Brown Joins Allergan's Board of Directorshttps://practicaldermatology.com/news/adriane-m-brown-joins-allergans-board-of-directors/2458375/Adriane M. Brown is joining Allergan’s board of directors effective February 2017. Ms. Brown is currently President and Chief Operating Officer of Intellectual Ventures LLC, a private global invention company focused on providing access to valua
- Mederma To Offer Products for Healthier Hair, Skin and Nailshttps://practicaldermatology.com/news/mederma-to-offer-products-for-healthier-hair-skin-and-nails/2458377/It’s not just scar and stretch mark reduction for Mederma anymore. Perhaps best known for such legacy products as scar gel and cream and stretch mark therapy, Mederma is now rolling out three new product lines for healthier hair, skin and nails.
- FDA OKS Santalis' Phase 2 Study of EISO For ADhttps://practicaldermatology.com/news/fda-oks-santalis-phase-2-study-of-eiso-in-ad/2458385/The U.S. Food and Drug Administration (FDA) has green lighted Santalis Pharmaceuticals Phase 2 clinical study of East Indian Sandalwood Oil (EISO) cream for the treatment of atopic dermatitis (AD). The multi-center, placebo controlled, double blinded, Phase 2 efficacy and tolerability stu